Alison Smith and Beth Shinkins are attending HTAi 2018 in Vancouver

Alison and Beth presented a workshop on Uncertainty and the Value of Precision Medicine on Saturday 2nd June

Alison Smith and Beth Shinkins presented a pre-conference workshop at the HTAi 2018 Annual Meeting. The workshop was entitled Uncertainty and the Value of Precision Medicine. Alison discussed “Uncertainty in the Lab” while Beth covered “Uncertainty in Test Evaluation for Precision Medicine”. The session was chaired by Chris McCabe (Executive Direction and CEO at the Institute of Health Economics & PI at the Precision Medicine Policy Network).  The half-day workshop was designed to promote an informed debate across the HTA community on systematic approaches to the incorporation of uncertainty in the evidence base for Precision Medicine into HTA analyses. 

Alison and Beth's attendance was  part funded by Genome Canada’s Precision Medicine Policy Network.